Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance

Journal of Infection

Volumn 71, Issue 3, 2015, Pages 385-394

  Fernández Ruiz, Mario ^a   Puig Asensio, Mireia ^b   Guinea, Jesús ^c   Almirante, Benito ^b   Padilla, Belén ^c   Almela, Manuel ^d   Díaz Martín, Ana ^e   Rodríguez Baño, Jesús ^f   Cuenca Estrella, Manuel ^g   Aguado, José María ^a   Muñoz, Patricia ^c   Paño Pardo, José Ramón ^h   García Rodríguez, Julio ^h   Cerrada, Carlos García ^h   Fortún, Jesús ⁱ   Martín, Pilar ⁱ   Gómez, Elia ⁱ   Ryan, Pablo ^j   Campelo, Carolina ^j   Gil, Ignacio de los Santos ^k   Buendía, Ventura ^k   Gorricho, Beatriz Perez ^l   Alonso, Mercedes ^l   Sanz, Francisca Sanz ^m   Merino, Paloma ⁿ   Romo, Fernando González ⁿ   Gorgolas, Miguel ^o   Gadea, Ignacio ^o   Losa, Juan Emilio ^p   Delgado Iribarren, Alberto ^p   Ramos, Antonio ^q   Romero, Yolanda ^q   Romero, Isabel Sánchez ^q   Zaragoza, Oscar ^g   Suarez, Ana Isabel ^f   Loza, Ana ^r   Aller García, Ana Isabel ^r   Martín Mazuelos, Estrella ^r   Pérez de Pipaón, Maite Ruiz ^e   Garnacho, José ^e   Ortiz, Carlos ^s   Chávez, Mónica ^t   Maroto, Fernando L ^t   Salavert, Miguel ^u   Pemán, Javier ^u   Blanquer, José ^v   Navarro, David ^v   Camarena, Juan José ^w   Zaragoza, Rafael ^w   Abril, Vicente ^x   Gimeno, Concepci ón ^x   Hernáez, Silvia ^y   Ezpeleta, Guillermo ^y   Bereciartua, Elena ^z   Hernández Almaraz, José L ^z   Montejo, Miguel ^z   Rivas, Rosa Ana ^aa   Ayarza, Rafael ^aa   Planes, Ana Ma ^b   Camps, Isabel Ruiz ^b   Mensa, José ^ab   Gurgui, Mercè ^ac   Sánchez Reus, Ferran ^ac   Martinez Montauti, Joaquin ^ad   Sierra, Montserrat ^ad   Horcajada, Juan Pablo ^ae   Sorli, Luisa ^ae   Gómez, Julià ^ae   Gené, Amadeu ^af   Urrea, Mireia ^af   Valerio, Maricela ^ag   Puchades, Francesc ^ag   Mularoni, Alessandra ^ag   more..

^a Universidad Complutense ^*  (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

^h HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

ⁱ HOSPITAL RAMÓN Y CAJAL   (Spain)

^j HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^k HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^l HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^m HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

ⁿ HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^o Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^p HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^q HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^r HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^s HOSPITAL QUIRÓN   (Spain)

^t HOSPITAL SAN JUAN DE DIOS DEL ALJARAFE   (Spain)

^u HOSPITAL UNIVERSITARIO LA FE   (Spain)

^v HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^w HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^x HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^y HOSPITAL DE BASURTO   (Spain)

^z HOSPITAL DE CRUCES   (Spain)

^aa HOSPITAL DE GALDAKAO   (Spain)

^ab INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^ac HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^ad Hospital de Niños de Barcelona   (Spain)

^ae HOSPITAL DEL MAR   (Spain)

^af HOSPITAL SANT JOAN DE DÉU   (Spain)

^ag Hospital del Mar ^*

more..

Author keywords

Candida tropicalis bloodstream infection; Epidemiology; Minimum inhibitory concentration; Outcome; Treatment

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOODSTREAM INFECTION; CANDIDIASIS; CATHETER REMOVAL; CLINICAL FEATURE; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; FEMALE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; INCIDENCE; LEUKEMIA; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; NONHUMAN; OUTCOME ASSESSMENT; POPULATION RESEARCH; RISK FACTOR; TREATMENT INDICATION; TREATMENT OUTCOME; ADVERSE EFFECTS; AGE; ANTIFUNGAL RESISTANCE; CANDIDA TROPICALIS; CANDIDEMIA; CENTRAL VENOUS CATHETER; DRUG EFFECTS; HEALTH SURVEY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; SPAIN; TIME FACTOR; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA TROPICALIS; CANDIDEMIA; CENTRAL VENOUS CATHETERS; COMORBIDITY; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; HUMANS; INCIDENCE; LEUKEMIA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TIME FACTORS; VORICONAZOLE;

EID: 84942817629     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.05.009     Document Type: Article

References (32)

1. Almirante B, Rodríguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005;43:1829-35
2. Peman J, Canton E, Quindos G, Eraso E, Alcoba J, Guinea J, et al. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother 2012;67:1181-7
3. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006;44:2816-23
4. Corzo-Leon DE, Alvarado-Matute T, Colombo AL, Cornejo-Juarez P, Cortés J, Echevarría JI, et al. Surveillance of Candida spp bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitals. PLoS One 2014;9:e97325.
5. Negri M, Silva S, Henriques M, Oliveira R. Insights into Candida tropicalis nosocomial infections and virulence factors. Eur J Clin Microbiol Infect Dis 2012;31:1399-412
6. Rodrigues AG, Pina-Vaz C, Costa-de-Oliveira S, Tavares C. Expression of plasma coagulase among pathogenic Candida species. J Clin Microbiol 2003;41:5792-3
7. Deorukhkar SC, Saini S, Mathew S. Virulence factors contributing to pathogenicity of Candida tropicalis and its antifungal susceptibility profile. Int J Microbiol 2014;2014: 456878.
8. Moralez AT, França EJ, Furlaneto-Maia L, Quesada RM, Furlaneto MC. Phenotypic switching in Candida tropicalis: association with modification of putative virulence attributes and antifungal drug sensitivity. Med Mycol 2014;52:106-14
9. Leung AY, Chim CS, Ho PL, Cheng VC, Yuen KY, Lie AK, et al. Candida tropicalis fungaemia in adult patients with haematological malignancies: clinical features and risk factors. J Hosp Infect 2002;50:316-9
10. Kontoyiannis DP, Vaziri I, Hanna HA, Boktour M, Thornby J, Hachem R, et al. Risk factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis 2001;33:1676-81
11. Muñoz P, Giannella M, Fanciulli C, Guinea J, Valerio M, Rojas L, et al. Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital. Clin Microbiol Infect 2011;17: 1538-45
12. Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 2012;54:1110-22
13. Nucci M, Colombo AL. Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Microbiol Infect Dis 2007;58:77-82
14. Pappas PG, Kauffman CA, Andes D, Benjamin Jr DK, Calandra TF, Edwards Jr JE, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48: 503-35
15. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 2012;18:19-37
16. Myoken Y, Kyo T, Fujihara M, Sugata T, Mikami Y. Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies. Haematologica 2004;89:378-80
17. Vandeputte P, Larcher G, Bergès T, Renier G, Chabasse D, Bouchara JP. Mechanisms of azole resistance in a clinical isolate of Candida tropicalis. Antimicrob Agents Chemother 2005;49:4608-15
18. Puig-Asensio M, Peman J, Zaragoza R, Garnacho-Montero J, Martín-Mazuelos E, Cuenca-Estrella M, et al. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect 2014;20:O245-54
19. Guinea J, Zaragoza O, Escribano P, Martín-Mazuelos E, Peman J, Sanchez-Reus F, et al. Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain from 2010 to 2011. Antimicrob Agents Chemother 2014;58:1529-37
20. Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis 2008; 47:674-83
21. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1-45
22. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, et al. Antibiotic therapy for Klebsiella pneumoniae bacteraemia: implications of production of extendedspectrum β-lactamases. Clin Infect Dis 2004;39:31-7
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
24. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 2008;14:398-405
25. White T, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gefland DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. San Diego, CA: Academic Press; 1990. p. 315-22
26. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard (third edition). CLSI document M27-A3. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
27. Forastiero A, Mesa-Arango AC, Alastruey-Izquierdo A, Alcazar-Fuoli L, Bernal-Martinez L, Pelaez T, et al. Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications. Antimicrob Agents Chemother 2013; 57:4769-81
28. Cisterna R, Ezpeleta G, Telleria OSpanish Candidemia Surveillance Group. Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain. J Clin Microbiol 2010;48:4200-6
29. Arendrup MC, Dzajic E, Jensen RH, Johansen HK, Kjaeldgaard P, Knudsen JD, et al. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme. Clin Microbiol Infect 2013;19: E343-53
30. Stevens DA, Espiritu M, Parmar R. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother 2004;48: 3407-11
31. Eagle H. A paradoxical zone phenomenon in the bactericidal action of penicillin in vitro. Science 1948;107:44-5
32. Clemons KV, Espiritu M, Parmar R, Stevens DA. Assessment of the paradoxical effect of caspofungin in therapy of candidiasis. Antimicrob Agents Chemother 2006;50:1293-7